Company profile for Ahngook Pharmaceutical

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Ahngook is a fully integrated pharmaceutical company dedicating to development, manufacture, marketing and sales of good medicines in Korea since 1959. Ahngook has many differentiated products and it's flexible for collaboration and business models to ensure for mutual benefits with its partners. For the future growth, Ahngook is concetrating its R&D efforts on Cardiovascular, Respiratory, Gastroenterology, Urology and other n...
Ahngook is a fully integrated pharmaceutical company dedicating to development, manufacture, marketing and sales of good medicines in Korea since 1959. Ahngook has many differentiated products and it's flexible for collaboration and business models to ensure for mutual benefits with its partners. For the future growth, Ahngook is concetrating its R&D efforts on Cardiovascular, Respiratory, Gastroenterology, Urology and other niche areas. Ahngook has its own entity in China and is trying to establish its presence outside Korea. In 2013, Ahngook entered several out-license agreements and distribution agreements with overseas partners.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
South Korea
Address
Address
#993-75, Daelim-Dong, Youngdungpo-Gu, Seoul 150-953
Telephone
Telephone
+82 232 894 359
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

BPI Europe

BPI Europe

Not Confirmed

envelop Contact Supplier

BPI Europe

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2026/03/11/3253727/0/en/George-Medicines-signs-exclusive-licensing-agreement-with-Ahngook-Pharmaceutical-to-commercialize-GMRx2-in-Korea.html

GLOBENEWSWIRE
12 Mar 2026

https://www.globenewswire.com/news-release/2026/03/11/3253727/0/en/George-Medicines-signs-exclusive-licensing-agreement-with-Ahngook-Pharmaceutical-to-commercialize-GMRx2-in-Korea.html

GLOBENEWSWIRE
11 Mar 2026

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty